More on CGON

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.4 Score)

Upcoming Events

- Earnings (8/7/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CG Oncology (NQ:CGON)
Delayed: 54.42 -1.11 (2%)
Prev. Close $55.53  
Open$55.34 
52 Wk High$ 
52 Wk Low$ 
Day High$56.99 
Day Low$54.02 
P/E N/A  
EPS$ 
Volume982,166 

Friends, Peers and Foes (?): ANIP, AMGN, ABBV, ARGX, ARWR (more...)

May 28, 2026 04:05 PM CG Oncology to Present at Upcoming Investor Conferences in June
May 26, 2026 08:00 AM Form 8-K CG Oncology, Inc. For: May 20
May 19, 2026 08:00 AM SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 19, 2026 05:32 AM Wolfe Research Starts CG Oncology (CGON) at Peerperform
May 18, 2026 10:17 AM UBS Reiterates Buy Rating on CG Oncology (CGON)
May 15, 2026 10:07 AM Form SCHEDULE 13G CG Oncology, Inc. Filed by: T. Rowe Price Investment Management, Inc.
May 15, 2026 08:16 AM Form SCHEDULE 13G CG Oncology, Inc. Filed by: RTW INVESTMENTS, LP
May 15, 2026 08:00 AM CG Oncology reports positive trial results for bladder cancer therapy
May 15, 2026 08:00 AM CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 14, 2026 06:08 AM CG Oncology (CGON) PT Raised to $82 at Truist Securities
View All Articles

Entities mentioned with CGON

View All Entities